396 related articles for article (PubMed ID: 17880529)
1. p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.
Liao XY; Xue WC; Shen DH; Ngan HY; Siu MK; Cheung AN
Histopathology; 2007 Oct; 51(4):477-83. PubMed ID: 17880529
[TBL] [Abstract][Full Text] [Related]
2. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
Esheba GE; Longacre TA; Atkins KA; Higgins JP
Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
[TBL] [Abstract][Full Text] [Related]
3. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
4. Ovarian transitional cell carcinoma represents a poorly differentiated form of high-grade serous or endometrioid adenocarcinoma.
Takeuchi T; Ohishi Y; Imamura H; Aman M; Shida K; Kobayashi H; Kato K; Oda Y
Am J Surg Pathol; 2013 Jul; 37(7):1091-9. PubMed ID: 23681072
[TBL] [Abstract][Full Text] [Related]
5. Transitional cell tumors of the ovary: a compact group with a heterogeneous histological and immunophenotypical pattern.
Ceauşu M; Terzea D; Georgescu A; Dobrea C; Mihai M; Iosif C; Vasilescu F; Ardeleanu C
Rom J Morphol Embryol; 2008; 49(4):513-6. PubMed ID: 19050800
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium.
Kuhn E; Ayhan A; Shih IeM; Seidman JD; Kurman RJ
Eur J Cancer; 2013 Dec; 49(18):3839-49. PubMed ID: 24012099
[TBL] [Abstract][Full Text] [Related]
7. Brenner and transitional cell tumours of the ovary. Report of three cases.
Rantanen V; Grénman S; Kiilholma P; Salmi T; Klemi PJ
Ann Chir Gynaecol Suppl; 1994; 208():28-32. PubMed ID: 8092766
[TBL] [Abstract][Full Text] [Related]
8. [Transitional cell tumors:malignant Brenner tumor and transitional cell carcinoma of the ovary].
Ianev N; Ivanova R; Gorchev G; Tsvetkov Ch; Veselinova T; Strateva D
Akush Ginekol (Sofiia); 2007; 46 Suppl 2():20-22. PubMed ID: 18219757
[No Abstract] [Full Text] [Related]
9. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
[TBL] [Abstract][Full Text] [Related]
10. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
11. p63 expression in ovarian tumours: immunopositivity in metastatic transitional cell carcinoma of the ovary.
Kalebi A; Hale M
Histopathology; 2008 Aug; 53(2):228. PubMed ID: 18518899
[No Abstract] [Full Text] [Related]
12. Transitional cell carcinoma of the endometrium associated with a benign ovarian Brenner tumor: a case report.
Labonté S; Têtu B; Boucher D; Larue H
Hum Pathol; 2001 Feb; 32(2):230-2. PubMed ID: 11230712
[TBL] [Abstract][Full Text] [Related]
13. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
14. Left ovarian Brenner tumor.
Heye S; Bielen D; Vanbeckevoort D
JBR-BTR; 2005; 88(5):245-6. PubMed ID: 16302335
[TBL] [Abstract][Full Text] [Related]
15. B7-H4 expression in Brenner tumours, a descriptive and comparative study.
Yee EU; Zaino RJ; Torkko KC; Shroyer KR
Histopathology; 2010 Apr; 56(5):652-4. PubMed ID: 20459576
[No Abstract] [Full Text] [Related]
16. Borderline and malignant Brenner tumours of the ovary. A report of 15 cases.
Hallgrìmsson J; Scully RE
Acta Pathol Microbiol Scand Suppl; 1972; 233():56-66. PubMed ID: 5074634
[No Abstract] [Full Text] [Related]
17. [Invasive urothelial carcinoma in bladder associated with bilateral benign ovarian Brenner tumor: report of a case].
Lu S; Pei F; Liao SL
Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):485-6. PubMed ID: 19781200
[No Abstract] [Full Text] [Related]
18. Proliferating Brenner tumour of ovary--a case report.
Samantaray S; Rout N; Mishra DP; Mallik RN
Indian J Pathol Microbiol; 2003 Oct; 46(4):641-2. PubMed ID: 15025364
[TBL] [Abstract][Full Text] [Related]
19. [Brenner tumor of the ovary--a clinicopathological report of 5 cases].
Li AY; Li XL; Xing LY
Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):218-220, 10. PubMed ID: 3447865
[TBL] [Abstract][Full Text] [Related]
20. FOXA1 is expressed in ovarian mucinous neoplasms.
Karpathiou G; Venet M; Mobarki M; Forest F; Chauleur C; Peoc'h M
Pathology; 2017 Apr; 49(3):271-276. PubMed ID: 28238418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
